Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Balkom_AJ:

Pharmacotherapy for social anxiety disorder (SAnD). Williams T et al. Cochrane Database Syst Rev. (2017)

New treatment models for compulsive disorders. Grant JE et al. Eur Neuropsychopharmacol. (2016)

Cost-effectiveness of interventions for treating anxiety disorders: A systematic review. Ophuis RH et al. J Affect Disord. (2017)

Search results

Items: 1 to 50 of 236

1.

Toward identifying reproducible brain signatures of obsessive-compulsive profiles: rationale and methods for a new global initiative.

Simpson HB, van den Heuvel OA, Miguel EC, Reddy YCJ, Stein DJ, Lewis-Fernández R, Shavitt RG, Lochner C, Pouwels PJW, Narayanawamy JC, Venkatasubramanian G, Hezel DM, Vriend C, Batistuzzo MC, Hoexter MQ, de Joode NT, Costa DL, de Mathis MA, Sheshachala K, Narayan M, van Balkom AJLM, Batelaan NM, Venkataram S, Cherian A, Marincowitz C, Pannekoek N, Stovezky YR, Mare K, Liu F, Otaduy MCG, Pastorello B, Rao R, Katechis M, Van Meter P, Wall M.

BMC Psychiatry. 2020 Feb 14;20(1):68. doi: 10.1186/s12888-020-2439-2.

2.

Childhood trauma and attachment style predict the four-year course of obsessive compulsive disorder: Findings from the Netherlands obsessive compulsive disorder study.

Tibi L, van Oppen P, van Balkom AJLM, Eikelenboom M, Hendriks GJ, Anholt GE.

J Affect Disord. 2020 Mar 1;264:206-214. doi: 10.1016/j.jad.2019.12.028. Epub 2019 Dec 20.

PMID:
32056752
3.

Prioritizing suicide prevention guideline recommendations in specialist mental healthcare: a Delphi study.

Setkowski K, van Balkom AJLM, Dongelmans DA, Gilissen R.

BMC Psychiatry. 2020 Feb 7;20(1):55. doi: 10.1186/s12888-020-2465-0.

4.

The impact of depression and anxiety treatment on biological aging and metabolic stress: study protocol of the MOod treatment with antidepressants or running (MOTAR) study.

Lever-van Milligen BA, Verhoeven JE, Schmaal L, van Velzen LS, Révész D, Black CN, Han LKM, Horsfall M, Batelaan NM, van Balkom AJLM, van Schaik DJF, van Oppen P, Penninx BWJH.

BMC Psychiatry. 2019 Dec 30;19(1):425. doi: 10.1186/s12888-019-2404-0.

5.

A clinical staging approach to improving diagnostics in anxiety disorders: Is it the way to go?

Bokma WA, Batelaan NM, Hoogendoorn AW, Penninx BW, van Balkom AJ.

Aust N Z J Psychiatry. 2020 Feb;54(2):173-184. doi: 10.1177/0004867419887804. Epub 2019 Dec 3.

PMID:
31793794
6.

Predictors of treatment outcome in OCD: An interpersonal perspective.

Tibi L, van Oppen P, van Balkom AJLM, Eikelenboom M, Emmelkamp PMG, Anholt GE.

J Anxiety Disord. 2019 Dec;68:102153. doi: 10.1016/j.janxdis.2019.102153. Epub 2019 Oct 24.

PMID:
31704634
7.

Four-year course of quality of life and obsessive-compulsive disorder.

Remmerswaal KCP, Batelaan NM, Hoogendoorn AW, van der Wee NJA, van Oppen P, van Balkom AJLM.

Soc Psychiatry Psychiatr Epidemiol. 2019 Sep 20. doi: 10.1007/s00127-019-01779-7. [Epub ahead of print]

PMID:
31541270
8.

Patient preferences for a guided self-help programme to prevent relapse in anxiety or depression: A discrete choice experiment.

Muntingh ADT, Hoogendoorn AW, Van Schaik DJF, Van Straten A, Stolk EA, Van Balkom AJLM, Batelaan NM.

PLoS One. 2019 Jul 18;14(7):e0219588. doi: 10.1371/journal.pone.0219588. eCollection 2019.

9.

Long-term disability in major depressive disorder: a 6-year follow-up study.

Iancu SC, Wong YM, Rhebergen D, van Balkom AJLM, Batelaan NM.

Psychol Med. 2019 Jul 9:1-9. doi: 10.1017/S0033291719001612. [Epub ahead of print]

PMID:
31284881
10.

The decision tool unipolar depression (DTUD): a new measure to facilitate the early identification of patients with major depressive disorder in need of highly specialized care.

van Krugten FCW, Goorden M, van Balkom AJLM, van Oppen P, Ruhé HG, van Schaik DJF, Brouwer WBF, Hakkaart-van Roijen L; Decision Tool Unipolar Depression Consortium.

BMC Psychiatry. 2019 Jun 11;19(1):179. doi: 10.1186/s12888-019-2165-9.

11.

[Relapse in anxiety disorders].

Muntingh ADT, Batelaan NM, van Balkom AJLM.

Ned Tijdschr Geneeskd. 2019 Feb 15;163. pii: D2785. Dutch.

PMID:
30816655
12.

Use of videotaped personal compulsions to enhance motivation in obsessive-compulsive disorder.

du Mortier JAM, Visser HAD, van Geijtenbeek-de Vos van Steenwijk MFR, van Megen HJGM, van Balkom AJLM.

BJPsych Open. 2019 Jan;5(1):e11. doi: 10.1192/bjo.2018.76.

13.

Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial.

van der Flier FE, Kwee CMB, Cath DC, Batelaan NM, Groenink L, Duits P, van der Veen DC, van Balkom AJLM, Baas JMP.

BMC Psychiatry. 2019 Feb 13;19(1):69. doi: 10.1186/s12888-019-2022-x.

14.

The GET READY relapse prevention programme for anxiety and depression: a mixed-methods study protocol.

Krijnen-de Bruin E, Muntingh ADT, Hoogendoorn AW, van Straten A, Batelaan NM, Maarsingh OR, van Balkom AJLM, van Meijel B.

BMC Psychiatry. 2019 Feb 11;19(1):64. doi: 10.1186/s12888-019-2034-6.

15.

Effectiveness of a self-management training for patients with chronic and treatment resistant anxiety or depressive disorders on quality of life, symptoms, and empowerment: results of a randomized controlled trial.

Zoun MHH, Koekkoek B, Sinnema H, van der Feltz-Cornelis CM, van Balkom AJLM, Schene AH, Smit F, Spijker J.

BMC Psychiatry. 2019 Jan 28;19(1):46. doi: 10.1186/s12888-019-2013-y.

16.

Prevalence and course of subthreshold anxiety disorder in the general population: A three-year follow-up study.

Bosman RC, Ten Have M, de Graaf R, Muntingh AD, van Balkom AJ, Batelaan NM.

J Affect Disord. 2019 Mar 15;247:105-113. doi: 10.1016/j.jad.2019.01.018. Epub 2019 Jan 15.

PMID:
30660019
17.

Obsessive compulsive disorder with and without hoarding symptoms: Characterizing differences.

Boerema YE, de Boer MM, van Balkom AJLM, Eikelenboom M, Visser HA, van Oppen P.

J Affect Disord. 2019 Mar 1;246:652-658. doi: 10.1016/j.jad.2018.12.115. Epub 2018 Dec 27.

PMID:
30611063
18.

Perceptions of free will in obsessive-compulsive disorder: a quantitative analysis.

van Oudheusden LJB, Draisma S, van der Salm S, Cath D, van Oppen P, van Balkom AJLM, Meynen G.

BMC Psychiatry. 2018 Dec 27;18(1):400. doi: 10.1186/s12888-018-1985-3.

19.

Examining the factor structure of the self-report Yale-Brown Obsessive Compulsive Scale Symptom Checklist.

du Mortier JAM, Visser HAD, van Balkom AJLM, van Megen HJGM, Hoogendoorn AW, Glas G, van Oppen P.

Psychiatry Res. 2019 Jan;271:299-305. doi: 10.1016/j.psychres.2018.11.042. Epub 2018 Nov 19.

PMID:
30521999
20.

Body mass index in obsessive-compulsive disorder.

Abramovitch A, Anholt GE, Cooperman A, van Balkom AJLM, Giltay EJ, Penninx BW, van Oppen P.

J Affect Disord. 2019 Feb 15;245:145-151. doi: 10.1016/j.jad.2018.10.116. Epub 2018 Oct 25.

PMID:
30388557
21.

Intraindividual variability in symptoms consistently predicts sudden gains: An examination of three independent datasets.

Shalom JG, Gilboa-Schechtman E, Atzil-Slonim D, Bar-Kalifa E, Hasson-Ohayon I, van Oppen P, van Balkom AJLM, Aderka IM.

J Consult Clin Psychol. 2018 Nov;86(11):892-902. doi: 10.1037/ccp0000344.

PMID:
30335422
22.

The cost-utility of stepped-care algorithms according to depression guideline recommendations - Results of a state-transition model analysis.

Meeuwissen JAC, Feenstra TL, Smit F, Blankers M, Spijker J, Bockting CLH, van Balkom AJLM, Buskens E.

J Affect Disord. 2019 Jan 1;242:244-254. doi: 10.1016/j.jad.2018.08.024. Epub 2018 Aug 9.

PMID:
30216769
23.

Feasibility and impact of data-driven learning within the suicide prevention action network of thirteen specialist mental healthcare institutions (SUPRANET Care) in the Netherlands: a study protocol.

Setkowski K, Mokkenstorm J, van Balkom AJ, Franx G, Verbeek-van Noord I, Dongelmans DA, Eikelenboom M, Gilissen R.

BMJ Open. 2018 Aug 20;8(8):e024398. doi: 10.1136/bmjopen-2018-024398.

24.

Failure to Respond after Reinstatement of Antidepressant Medication: A Systematic Review.

Bosman RC, Waumans RC, Jacobs GE, Oude Voshaar RC, Muntingh ADT, Batelaan NM, van Balkom AJLM.

Psychother Psychosom. 2018;87(5):268-275. doi: 10.1159/000491550. Epub 2018 Jul 24. Review.

25.

The Efficacy of a Group CBT Relapse Prevention Program for Remitted Anxiety Disorder Patients Who Discontinue Antidepressant Medication: A Randomized Controlled Trial.

Scholten WD, Batelaan NM, van Oppen P, Smit JH, Hoogendoorn AW, van Megen HJGM, Cath DC, van Balkom AJLM.

Psychother Psychosom. 2018;87(4):240-242. doi: 10.1159/000489498. Epub 2018 Jun 1. No abstract available.

26.

Indicators to facilitate the early identification of patients with major depressive disorder in need of highly specialized care: A concept mapping study.

van Krugten FCW, Goorden M, van Balkom AJLM, Spijker J, Brouwer WBF, Hakkaart-van Roijen L; Decision Tool Unipolar Depression Consortium.

Depress Anxiety. 2018 Apr;35(4):346-352. doi: 10.1002/da.22741. Epub 2018 Mar 25.

27.

Chronic obsessive-compulsive disorder: prognostic factors.

van Oudheusden LJB, Eikelenboom M, van Megen HJGM, Visser HAD, Schruers K, Hendriks GJ, van der Wee N, Hoogendoorn AW, van Oppen P, van Balkom AJLM.

Psychol Med. 2018 Oct;48(13):2213-2222. doi: 10.1017/S0033291717003701. Epub 2018 Jan 9.

PMID:
29310732
28.

[Matched care for complex PTSD: what works for whom?]

Dorrepaal E, Thomaes K, Veltman DJ, van Balkom AJLM, Draijer N.

Tijdschr Psychiatr. 2017;59(11):680-681. Dutch. No abstract available.

29.

Long-Term and Short-Term Antidepressant Use in General Practice: Data from a Large Cohort in the Netherlands.

Huijbregts KM, Hoogendoorn A, Slottje P, van Balkom AJLM, Batelaan NM.

Psychother Psychosom. 2017;86(6):362-369. doi: 10.1159/000480456. Epub 2017 Nov 3.

PMID:
29131110
30.

Pharmacotherapy for social anxiety disorder (SAnD).

Williams T, Hattingh CJ, Kariuki CM, Tromp SA, van Balkom AJ, Ipser JC, Stein DJ.

Cochrane Database Syst Rev. 2017 Oct 19;10:CD001206. doi: 10.1002/14651858.CD001206.pub3. Review.

31.

Cognitive control networks in OCD: A resting-state connectivity study in unmedicated patients with obsessive-compulsive disorder and their unaffected relatives.

de Vries FE, de Wit SJ, van den Heuvel OA, Veltman DJ, Cath DC, van Balkom AJLM, van der Werf YD.

World J Biol Psychiatry. 2019 Mar;20(3):230-242. doi: 10.1080/15622975.2017.1353132. Epub 2017 Sep 18.

PMID:
28918693
32.
33.

The relationship between cognitions and symptoms in obsessive-compulsive disorder.

Tibi L, van Oppen P, van Balkom AJLM, Eikelenboom M, Hendriks GJ, Anholt GE.

J Affect Disord. 2018 Jan 1;225:495-502. doi: 10.1016/j.jad.2017.08.072. Epub 2017 Aug 30.

PMID:
28865371
34.

No Effects of D-Cycloserine Enhancement in Exposure With Response Prevention Therapy in Panic Disorder With Agoraphobia: A Double-Blind, Randomized Controlled Trial.

Hofmeijer-Sevink MK, Duits P, Rijkeboer MM, Hoogendoorn AW, van Megen HJ, Vulink NC, Denys DA, van den Hout MA, van Balkom AJ, Cath DC.

J Clin Psychopharmacol. 2017 Oct;37(5):531-539. doi: 10.1097/JCP.0000000000000757.

PMID:
28820746
35.

Collaborative Care for Anxiety Disorders in Primary Care: a Systematic Review and Meta-Analysis.

Muntingh AD, van der Feltz-Cornelis CM, van Marwijk HW, Spinhoven P, van Balkom AJ.

Focus (Am Psychiatr Publ). 2017 Jul;15(3):333-346. doi: 10.1176/appi.focus.15303. Epub 2017 Jul 12.

36.

Admixture analysis of age of onset in generalized anxiety disorder.

Rhebergen D, Aderka IM, van der Steenstraten IM, van Balkom AJLM, van Oppen P, Stek ML, Comijs HC, Batelaan NM.

J Anxiety Disord. 2017 Aug;50:47-51. doi: 10.1016/j.janxdis.2017.05.003. Epub 2017 May 10.

PMID:
28554154
37.

The long-term association of OCD and depression and its moderators: A four-year follow up study in a large clinical sample.

Tibi L, van Oppen P, van Balkom AJLM, Eikelenboom M, Rickelt J, Schruers KRJ, Anholt GE.

Eur Psychiatry. 2017 Jul;44:76-82. doi: 10.1016/j.eurpsy.2017.03.009. Epub 2017 Apr 7.

PMID:
28545012
38.

Presence and Predictive Value of Obsessive-Compulsive Symptoms in Anxiety and Depressive Disorders.

Hofmeijer-Sevink MK, Batelaan NM, van Megen HJGM, van den Hout MA, Penninx BW, van Balkom AJLM, Cath DC.

Can J Psychiatry. 2018 Feb;63(2):85-93. doi: 10.1177/0706743717711170. Epub 2017 May 16.

39.

Impact of Anxiety and/or Depressive Disorders and Chronic Somatic Diseases on disability and work impairment.

Bokma WA, Batelaan NM, van Balkom AJ, Penninx BW.

J Psychosom Res. 2017 Mar;94:10-16. doi: 10.1016/j.jpsychores.2017.01.004. Epub 2017 Jan 6.

PMID:
28183397
40.

Indicators of patients with major depressive disorder in need of highly specialized care: A systematic review.

van Krugten FC, Kaddouri M, Goorden M, van Balkom AJ, Bockting CL, Peeters FP, Hakkaart-van Roijen L; Decision Tool Unipolar Depression (DTUD) Consortium.

PLoS One. 2017 Feb 8;12(2):e0171659. doi: 10.1371/journal.pone.0171659. eCollection 2017. Review.

41.

The Prognostic Effect of Physical Health Complaints With New Cardiac Events and Mortality in Patients With a Myocardial Infarction.

Van Beek MH, Roest AM, Wardenaar KJ, Van Balkom AJ, Speckens AE, Oude Voshaar RC, Zuidersma M.

Psychosomatics. 2017 Mar - Apr;58(2):121-131. doi: 10.1016/j.psym.2016.10.009. Epub 2016 Nov 5.

PMID:
28159352
42.

Cost-effectiveness of interventions for treating anxiety disorders: A systematic review.

Ophuis RH, Lokkerbol J, Heemskerk SC, van Balkom AJ, Hiligsmann M, Evers SM.

J Affect Disord. 2017 Mar 1;210:1-13. doi: 10.1016/j.jad.2016.12.005. Epub 2016 Dec 13. Review.

PMID:
27988373
43.

Prognostic association of cardiac anxiety with new cardiac events and mortality following myocardial infarction.

Van Beek MH, Zuidersma M, Lappenschaar M, Pop G, Roest AM, Van Balkom AJ, Speckens AE, Voshaar RC.

Br J Psychiatry. 2016 Nov;209(5):400-406. Epub 2016 Aug 18.

PMID:
27539297
44.

Tic-Related Versus Tic-Free Obsessive-Compulsive Disorder: Clinical Picture and 2-Year Natural Course.

de Vries FE, Cath DC, Hoogendoorn AW, van Oppen P, Glas G, Veltman DJ, van den Heuvel OA, van Balkom AJ.

J Clin Psychiatry. 2016 Oct;77(10):e1240-e1247. doi: 10.4088/JCP.14m09736.

PMID:
27631146
45.

Anxiety, depression and autonomy-connectedness: The mediating role of alexithymia and assertiveness.

Rutten EA, Bachrach N, van Balkom AJ, Braeken J, Ouwens MA, Bekker MH.

Psychol Psychother. 2016 Dec;89(4):385-401. doi: 10.1111/papt.12083. Epub 2015 Oct 24.

PMID:
26499179
46.

Long-term antidepressant use: a qualitative study on perspectives of patients and GPs in primary care.

Bosman RC, Huijbregts KM, Verhaak PF, Ruhé HG, van Marwijk HW, van Balkom AJ, Batelaan NM.

Br J Gen Pract. 2016 Oct;66(651):e708-19. doi: 10.3399/bjgp16X686641. Epub 2016 Aug 15.

47.

Effectiveness and cost-effectiveness of a self-management training for patients with chronic and treatment resistant anxiety or depressive disorders: design of a multicenter randomized controlled trial.

Zoun MH, Koekkoek B, Sinnema H, Muntingh AD, van Balkom AJ, Schene AH, Smit F, Spijker J.

BMC Psychiatry. 2016 Jul 7;16:216. doi: 10.1186/s12888-016-0927-1.

48.

The relation between depressive and obsessive-compulsive symptoms in obsessive-compulsive disorder: Results from a large, naturalistic follow-up study.

Rickelt J, Viechtbauer W, Lieverse R, Overbeek T, van Balkom AJ, van Oppen P, van den Heuvel OA, Marcelis M, Eikelenboom M, Tibi L, Schruers KR.

J Affect Disord. 2016 Oct;203:241-247. doi: 10.1016/j.jad.2016.06.009. Epub 2016 Jun 6.

PMID:
27310102
49.

Response to Crisp and Sullivan-Bissett.

Widdershoven GAM, Ruissen A, van Balkom AJLM, Meynen G.

J Med Ethics. 2017 Jun;43(6):382-383. doi: 10.1136/medethics-2016-103631. Epub 2016 Jun 9. No abstract available.

PMID:
27288097
50.

Collaborative care for anxiety disorders in primary care: a systematic review and meta-analysis.

Muntingh AD, van der Feltz-Cornelis CM, van Marwijk HW, Spinhoven P, van Balkom AJ.

BMC Fam Pract. 2016 Jun 2;17:62. doi: 10.1186/s12875-016-0466-3. Review.

Support Center